4//SEC Filing
Driscoll Martin J 4
Accession 0001209191-18-003917
CIK 0001566373other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:04 PM ET
Size
5.4 KB
Accession
0001209191-18-003917
Insider Transaction Report
Form 4
Driscoll Martin J
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2018-01-16+80,000→ 80,000 totalExercise: $12.10Exp: 2028-01-16→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 16, 2018, with 25% of the shares subject to the option vesting on January 16, 2019 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001339402
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:04 PM ET
- Size
- 5.4 KB